Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma. Fennell DA, Dulloo S. J Thorac Oncol 2022;17:34-37.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fennell DA, Dulloo S. Chemotherapy With or Without Bevacizumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma. J Thorac Oncol 2022;17:34-37.
PMID: 34930610